Background Human immunodeficiency virus (HIV)-associated neurocognitive disorders
persist in the era of antiretroviral therapy. One factor that is elevated among persons with …

It has long been known that human immunodeficiency virus (HIV) uses the central nervous
system (CNS) as a reservoir and nursery to replicate; therein, it does damage to cells and …

Objective: Methamphetamine and cannabis are two widely used substances among people
living with HIV (PLWH). Whereas methamphetamine use has been found to worsen HIV …

Background: Aging and HIV have adverse effects on the central nervous system, including
increased inflammation and neural injury and confer risk of neurocognitive impairment …

Background: Neurocognitive impairment is a frequent and often disabling comorbidity of HIV
infection. In addition to antiretroviral therapies, individuals with HIV infection may commonly …

Among severely mentally ill (SMI) substance abusers, HIV rates are elevated and HIV risk
reduction interventions have been shown to be less effective. An enhanced cognitive …

Neuropsychological (NP) dysfunction has been linked to poor medication adherence among
HIV-infected adults. However, there is a dearth of research examining longitudinal changes …

The acute and early period of HIV-1 infection (AEH) is characterized by neuroinflammatory
and immunopathogenic processes that can alter the integrity of neural systems and …

Objective: HIV infection and current substance use (SU) are linked to cognitive and
functional deficits, yet findings on their combined effects are mixed. Neurocognitive …

Background Substance use is common among people with human immunodeficiency virus
(HIV) infection. Alcohol, marijuana, and HIV can have negative effects on cognition …